Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Biology|May 17, 2014
High intensity training improves health and physical function in middle aged adultsSimon Adamson, Ross Lorimer, James N Cobley, et al.Drug and Alcohol Review|September 17, 2004
Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaireDaryle Deering, Christopher Frampton, Jacqueline Horn, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 7, 2018
Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmissionWiebke Bartels, Simon Adamson, Lisa Leung, et al.International Journal of Mental Health Nursing|December 23, 2003
Alcohol and drug treatment for women: clinicians' beliefs and practiceLois Cowan, Daryle Deering, Marie Crowe, et al.Cannabis and Cannabinoid Research|September 2, 2017
Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-FormMarcel O Bonn-Miller, Adrienne J Heinz, Everett V Smith, et al.Journal of Studies on Alcohol and Drugs|May 13, 2017
Postgraduate Alcohol and Other Drug Practitioner Training in New Zealand: Significant InfluencesPeter J Adams, Doug Sellman, David Newcombe, et al.Drug and Alcohol Review|April 15, 2021
Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sampleAmandine Luquiens, Aurélie Berger-Viergat, Agathe Larrieu, et al.Journal of Psychopharmacology (Oxford, England)|June 24, 2023
The New Zealand drug harms ranking study: A multi-criteria decision analysisRose Crossin, Lana Cleland, Chris Wilkins, et al.Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.Pageof 3